Who invested in Cognition Therapeutics?
Cognition Therapeutics's investors include Innovation Works, Pittsburgh Life Sciences Greenho, Ogden Capital, M5Invest Partners and Golden Seeds, and 10 more on record.
United States · Series B startup
10 rounds we have observed, with the 15 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$29Mraised across 10 rounds since 2007, from 10 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $16M sold, first sale Mar 2014
From a historical funding recordSEC filing: $6.0M sold, first sale Mar 2014
Reported by finsmes.comSEC filing: $3.0M sold, first sale Dec 2012
No investor was named in the report.
Reported by bizjournals.comSEC filing: $3.0M sold, first sale Dec 2012
No investor was named in the report.
Reported by sec.govSEC filing: $1.9M sold, first sale Dec 2012
From a historical funding recordSEC filing: $1.9M sold, first sale Dec 2012
Reported by sec.govSEC filing: $1.8M sold, first sale Dec 2011
Reported by finsmes.com
Reported by cogrx.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Cognition Therapeutics's investors include Innovation Works, Pittsburgh Life Sciences Greenho, Ogden Capital, M5Invest Partners and Golden Seeds, and 10 more on record.
Cognition Therapeutics has raised $29M across 10 rounds since 2007. One round did not disclose an amount, so the total is a floor.
Cognition Therapeutics's most recent round was a Series B of $12M in Sept 2015.
Its most recent round, $12M in Sept 2015, is also its largest on record.
Cognition Therapeutics's first round on record, in Nov 2007, was backed by Pittsburgh Life Sciences Greenho.
Cognition Therapeutics's latest named round is a Series B, in Sept 2015.
Cognition Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.